To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MSX2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
101 supporting clones for gene MSX2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN295824 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1 to 626 1 to 626   tiling clone,   626/626
(100 %)
2 diff
(99.7 %id)
AL552909 placenta, Placenta Cot 25-normalized .a 40 to 1036 1 to 996 P46A F47L S48Q V49R E50G ...     996/996
(100 %)
8 diff
(99.2 %id)
NM_002449.4   .a 40 to 2246 1 to 2207 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2207/2207
(100 %)
0 diff
(100 %id)
CN295809 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 48 to 776 1 to 729       729/729
(100 %)
7 diff
(99.1 %id)
AL542287 placenta .a 57 to 765 18 to 724       707/724
(97 %)
7 diff
(99.1 %id)
CN295806 embryonic stem cells, DMSO-treated H9 cellline .a 64 to 455 1 to 392       392/392
(100 %)
6 diff
(98.5 %id)
CN295825 embryonic stem cells, DMSO-treated H9 cellline .a 64 to 801 1 to 738       738/738
(100 %)
4 diff
(99.5 %id)
CN295812 embryonic stem cells, DMSO-treated H9 cellline .a 67 to 775 10 to 719       710/719
(98 %)
3 diff
(99.6 %id)
CN295819 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 67 to 269 10 to 212       203/212
(95 %)
0 diff
(100 %id)
D31771 tooth pulp of third molar .a 67 to 1229 1 to 1164 M129T     1164/1164
(100 %)
2 diff
(99.9 %id)
D89377 lower third molar .a 67 to 2246 1 to 2182 M129T tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2182/2182
(100 %)
10 diff
(99.6 %id)
BI092044 cervix .a 67 to 691 12 to 637       626/637
(98 %)
3 diff
(99.6 %id)
BU931083 ovary, teratocarcinoma, cell line .a 68 to 910 1 to 852       852/909
(93 %)
18 diff
(98.1 %id)
CR592938 Neuroblastoma Cot 25-normalized .a 72 to 1209 1 to 1138 exact tiling clone,   1138/1138
(100 %)
0 diff
(100 %id)
AL528158 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 72 to 507 1 to 436       436/1058
(41 %)
2 diff
(99.9 %id)
CN295817 embryonic stem cells, DMSO-treated H9 cellline .a 73 to 567 1 to 495       495/495
(100 %)
0 diff
(100 %id)
DR004761 placenta .a 75 to 702 1 to 626       626/626
(100 %)
23 diff
(96.4 %id)
CB992823 placenta, pre-eclamptic placenta .a 77 to 485 21 to 433       413/455
(90 %)
6 diff
(98.7 %id)
CN295816 embryonic stem cells, DMSO-treated H9 cellline .a 79 to 815 1 to 736       736/736
(100 %)
7 diff
(99.1 %id)
CN295811 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 85 to 308 1 to 225       225/225
(100 %)
7 diff
(96.9 %id)
CN295813 embryonic stem cells, DMSO-treated H9 cellline .a 93 to 670 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
AL550393 placenta, Placenta Cot 25-normalized .a 97 to 1033 40 to 963 M129T A195P K196R A197R R199D ...     924/1039
(88 %)
15 diff
(98.6 %id)
D26145 placenta .a 102 to 2240 1 to 2136 D14Y P26R P28W G30A A31E ... AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2136/2136
(100 %)
17 diff
(99.3 %id)
BC015509 Pancreas, epithelioid carcinoma .a 105 to 1232 1 to 1128 M129T available from MGC, AAA   1128/1128
(100 %)
1 diff
(100.0 %id)
BM479795 eye, retinoblastoma .a 107 to 1026 13 to 943 M129T Q191P N192E R193P R194K ...     931/1047
(88 %)
26 diff
(97.6 %id)
CN295807 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 110 to 567 1 to 458       458/458
(100 %)
3 diff
(99.4 %id)
CN295814 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 114 to 850 1 to 736       736/736
(100 %)
3 diff
(99.6 %id)
TI_1948153764   .a 121 to 814 117 to 814       698/1366
(51 %)
25 diff
(98.2 %id)
BE908476 epithelioid carcinoma, Pancreas .a 126 to 804 1 to 692       692/693
(99 %)
35 diff
(95.0 %id)
TI_1948153906   .a 126 to 884 121 to 896       776/1418
(54 %)
39 diff
(97.3 %id)
BT009814   .a 128 to 930 1 to 803       803/804
(99 %)
2 diff
(99.8 %id)
CV023740 mixed .a 128 to 277 1 to 150       150/150
(100 %)
2 diff
(98.7 %id)
CN295821 embryonic stem cells, cell lines H1, H7, andH9 .a 131 to 698 13 to 579       567/579
(97 %)
1 diff
(99.9 %id)
CN295808 embryonic stem cells, cell lines H1, H7, andH9 .a 302 to 774 1 to 473       473/473
(100 %)
4 diff
(99.2 %id)
CN295810 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 353 to 1131 1 to 779       779/779
(100 %)
6 diff
(99.3 %id)
BE093074 breast .a 409 to 678 286 to 17     Submitted on the opposite strand 270/286
(94 %)
0 diff
(100 %id)
D14970 ovary .a 413 to 2220 1 to 1804       1804/1804
(100 %)
14 diff
(99.3 %id)
AL552194 placenta, Placenta Cot 25-normalized .a 423 to 1000 351 to 927 G23E P24T G25R P28A G29W ...     896/978
(91 %)
56 diff
(94.3 %id)
CR622800 Placenta Cot 25-normalized .a 468 to 1209 1 to 742       742/742
(100 %)
0 diff
(100 %id)
AL528157 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 507 to 1209 703 to 1       703/1067
(65 %)
12 diff
(98.9 %id)
R08437 liver and spleen .a 512 to 802 1 to 301       301/301
(100 %)
15 diff
(95.1 %id)
CN295823 embryonic stem cells, cell lines H1, H7, andH9 .a 517 to 1178 1 to 662       662/662
(100 %)
0 diff
(100 %id)
N25434 melanocyte .a 517 to 978 1 to 466   fully sequenced,   466/466
(100 %)
9 diff
(98.1 %id)
TI_157600016   .a 517 to 1225 806 to 94   AAA   713/838
(85 %)
12 diff
(98.6 %id)
CV807139 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 523 to 1256 1 to 733       733/733
(100 %)
1 diff
(99.9 %id)
CN295826 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 526 to 1256 1 to 730       730/730
(100 %)
1 diff
(99.9 %id)
AW937985 denis_drash .a 552 to 712 1 to 161       161/161
(100 %)
1 diff
(99.4 %id)
BI050980 placenta_normal .a 602 to 990 390 to 4       387/390
(99 %)
0 diff
(100 %id)
H03276 placenta .a 634 to 951 1 to 322   fully sequenced,   322/322
(100 %)
12 diff
(96.3 %id)
AI218508 pooled .a 660 to 1233 569 to 1       569/575
(98 %)
21 diff
(96.4 %id)
CF529233 placenta .a 681 to 1225 563 to 19   AAA   545/545
(100 %)
0 diff
(100 %id)
BX396092 Placenta Cot 25-normalized .a 693 to 1209 1 to 515   fully sequenced,   515/515
(100 %)
2 diff
(99.7 %id)
AA775572 heart .a 694 to 1228 538 to 5       534/538
(99 %)
0 diff
(100 %id)
TI_157604648   .a 708 to 1225 616 to 99   AAA   518/760
(68 %)
14 diff
(98.2 %id)
BQ013723 placenta .a 714 to 1225 531 to 18   AAA   514/519
(99 %)
2 diff
(99.7 %id)
BF590810 colon, colon tumor, RER+ .a 719 to 926 208 to 1       208/214
(97 %)
6 diff
(97.2 %id)
AI628279 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 764 to 1249 509 to 26       484/509
(95 %)
0 diff
(100 %id)
AW079729 esophagus, squamous cell carcinoma .a 777 to 1020 244 to 1       244/244
(100 %)
7 diff
(97.2 %id)
AA725138 parathyroid gland, parathyroid tumor .a 792 to 1222 426 to 1       426/438
(97 %)
16 diff
(96.4 %id)
BF801010 colon_ins .a 800 to 1095 299 to 2     Submitted on the opposite strand 298/299
(99 %)
0 diff
(100 %id)
AW393137 stomach .a 803 to 1094 294 to 1       294/294
(100 %)
10 diff
(96.6 %id)
BF800219 colon_ins .a 821 to 1095 286 to 11     Submitted on the opposite strand 276/286
(96 %)
0 diff
(100 %id)
BX329936 Placenta Cot 25-normalized .a 839 to 1230 392 to 1   fully sequenced,   392/392
(100 %)
1 diff
(99.8 %id)
BE866539 bladder, carcinoma, cell line .a 856 to 1269 1 to 416       416/487
(85 %)
10 diff
(98.0 %id)
H40539 liver and spleen .a 877 to 1233 363 to 5       359/365
(98 %)
0 diff
(100 %id)
AW938007 denis_drash .a 882 to 1075 194 to 1     Submitted on the opposite strand 194/194
(100 %)
0 diff
(100 %id)
R27619 placenta .a 889 to 1232 361 to 1       361/418
(86 %)
21 diff
(95.0 %id)
BF886498 testis_normal .a 905 to 1043 139 to 1     Submitted on the opposite strand 139/139
(100 %)
0 diff
(100 %id)
BF909579 uterus_tumor .a 905 to 1056 1 to 152       152/157
(96 %)
12 diff
(92.4 %id)
H03277 placenta .a 921 to 1229 330 to 17   fully sequenced, AAA   314/321
(97 %)
6 diff
(98.2 %id)
N20373 melanocyte .a 948 to 1222 275 to 1   fully sequenced,   275/275
(100 %)
1 diff
(99.7 %id)
CN295818 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 949 to 1227 1 to 279       279/279
(100 %)
0 diff
(100 %id)
BX279937 placenta .a 979 to 1428 7 to 457       451/458
(98 %)
5 diff
(99.0 %id)
BQ010957 placenta .a 991 to 1225 253 to 19   AAA   235/235
(100 %)
1 diff
(99.6 %id)
AL576075 placenta, Placenta Cot 25-normalized .a 1168 to 2193 1025 to 1       1025/1025
(100 %)
14 diff
(98.7 %id)
AL575560 placenta, Placenta Cot 25-normalized .a 1186 to 2191 1005 to 1       1005/1064
(94 %)
25 diff
(97.7 %id)
W38629 parathyroid gland, parathyroid tumor .a 1188 to 1546 1 to 362   tiling clone,   362/362
(100 %)
7 diff
(98.1 %id)
BE866337 bladder, carcinoma, cell line .a 1227 to 1770 1 to 559       559/764
(73 %)
36 diff
(95.3 %id)
W37289 parathyroid gland, parathyroid tumor .a 1233 to 1824 1 to 598       598/609
(98 %)
16 diff
(97.4 %id)
AL542286 placenta .a 1237 to 1849 698 to 83   AAA   616/661
(93 %)
26 diff
(96.1 %id)
AL550352 placenta, Placenta Cot 25-normalized .a 1242 to 2215 970 to 4       967/970
(99 %)
0 diff
(100 %id)
AI122790 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1277 to 1922 648 to 1       648/757
(85 %)
31 diff
(96.0 %id)
CR606816 Placenta Cot 25-normalized .a 1383 to 2213 1 to 831   tiling clone,   831/831
(100 %)
0 diff
(100 %id)
AL574297 placenta, Placenta Cot 25-normalized .a 1383 to 2179 805 to 5       801/805
(99 %)
0 diff
(100 %id)
AI619632 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1419 to 1924 505 to 1       505/505
(100 %)
30 diff
(94.1 %id)
AW391118 stomach .a 1432 to 1805 12 to 386       375/386
(97 %)
0 diff
(100 %id)
AA194037 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1516 to 1799 1 to 294       294/294
(100 %)
11 diff
(96.3 %id)
T28264 colon, embryo .a 1550 to 1881 1 to 332       332/332
(100 %)
1 diff
(99.7 %id)
AW949481   .a 1551 to 2169 1 to 620       620/621
(99 %)
5 diff
(99.2 %id)
BQ010767 placenta .a 1560 to 1924 380 to 16   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 365/366
(99 %)
0 diff
(100 %id)
FN120628 breast carcinoma .a 1612 to 1728 117 to 1     Submitted on the opposite strand 117/118
(99 %)
5 diff
(95.8 %id)
TI_151756187   .a 1647 to 2244 685 to 87       599/1011
(59 %)
0 diff
(100 %id)
BM718207 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1651 to 2093 1 to 444       444/444
(100 %)
4 diff
(99.1 %id)
AI191653 heart .a 1655 to 2221 566 to 3       564/566
(99 %)
0 diff
(100 %id)
AI138926 placenta .a 1725 to 2223 510 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 500/500
(100 %)
1 diff
(99.8 %id)
AA843386 parathyroid gland, parathyroid tumor .a 1743 to 2239 498 to 1       498/498
(100 %)
27 diff
(94.6 %id)
W44734 parathyroid gland, parathyroid tumor .a 1753 to 2226 479 to 5       475/480
(98 %)
0 diff
(100 %id)
AA772539 parathyroid gland, parathyroid tumor .a 1759 to 2223 477 to 12   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 466/466
(100 %)
5 diff
(99.0 %id)
AA725181 parathyroid gland, parathyroid tumor .a 1770 to 2224 459 to 1       459/459
(100 %)
45 diff
(90.2 %id)
CN295820 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1818 to 2015 1 to 199       199/199
(100 %)
2 diff
(99.0 %id)
W37823 parathyroid gland, parathyroid tumor .a 1842 to 2242 411 to 1       411/412
(99 %)
14 diff
(96.7 %id)
AA195636 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1896 to 2241 355 to 3       353/356
(99 %)
0 diff
(100 %id)
AI540388 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1929 to 2223 301 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 291/336
(86 %)
12 diff
(96.5 %id)
DA078389 cerebellum .b-u 1 to 575 2 to 576 exact tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
AW239532 lung, cell line .b-u 17 to 431 1 to 415       415/415
(100 %)
2 diff
(99.6 %id)
BX387856 Placenta Cot 25-normalized Gene MSX2, variant not shown         This clone was ignored    
BX387857 Placenta Cot 25-normalized Gene MSX2, variant not shown         This clone was ignored    
CN295815 embryonic stem cells, DMSO-treated H9 cellline Gene MSX2, variant not shown         Suspected internal deletion, this clone was ignored    
CN295822 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene MSX2, variant not shown         This clone was ignored    
S75361   Gene MSX2, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
AI738443 colon, colon tumor, RER+ Gene MSX2, variant not shown         Suspected internal deletion, this clone was ignored    
BE902743 choriocarcinoma, placenta Gene MSX2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI